MedRhythms, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-13.
MedRhythms, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 13, 2026. The filing reports $250K sold. Its industry group is Other Technology. It names Brian Harris (Executive Officer, Director), Owen McCarthy (Executive Officer, Director), Jean Hoffman (Director) (SEC Form D, October 13, 2026).
Sell to companies like MedRhythms, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns MedRhythms, Inc.
Free to see. No signup.
More on the people and the money behind MedRhythms, Inc., from the filings we hold.
Other Technology raises filed within 90 days of this one, largest first.
Get an email when MedRhythms, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when MedRhythms, Inc. raises, hires or launches. No email unless you switch it on.
Watch MedRhythms, Inc. →Get the full cited report on MedRhythms, Inc.
What the filing shows about MedRhythms, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on MedRhythms, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for MedRhythms, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $250K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
MedRhythms develops next-generation neurotherapeutics and medical devices that deliver rhythmic auditory stimulation (RAS) to support walking
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Brian Harris is named as Executive Officer and Director on the Form D that MedRhythms, Inc. filed with the SEC on 13 October 2026, one of 7 people that filing names.
Owen McCarthy is named as Executive Officer and Director on the Form D that MedRhythms, Inc. filed with the SEC on 13 October 2026, one of 7 people that filing names.
Jean Hoffman is named as Director on the Form D that MedRhythms, Inc. filed with the SEC on 13 October 2026, one of 7 people that filing names.
Musan Duric is named as Director on the Form D that MedRhythms, Inc. filed with the SEC on 13 October 2026, one of 7 people that filing names.
Christopher Harris is named as Director on the Form D that MedRhythms, Inc. filed with the SEC on 13 October 2026, one of 7 people that filing names.
William McKee is named as Director on the Form D that MedRhythms, Inc. filed with the SEC on 13 October 2026, one of 7 people that filing names.
Isaac Cheng is named as Director on the Form D that MedRhythms, Inc. filed with the SEC on 13 October 2026, one of 7 people that filing names.
7 people named on the filing — 2 holding an executive role and 5 as directors only.
Named as of the 2026-10-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about MedRhythms, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on MedRhythms, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MedRhythms, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist MedRhythms, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind MedRhythms, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-16 (medrhythms.com).
Each opens in a new tab, filled in for MedRhythms, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-10-12 · AI and software raises, week of 2026-10-12
https://mentionfox.com/funding/medrhythms-inc-form-d-000003